Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perclose Inc.

Division of Abbott Laboratories Inc.
www.perclose.com

Latest From Perclose Inc.

Vascular Closure Market Makes Room For Innovative Solutions

The $1 billion vascular closure market is primed for growth. It comes on the back of intensive R&D that has spawned a range of alternatives to the traditional manual/compression approach, giving SJM and the sector’s other heavyweights cause to look over their shoulders.

Medical Device Surgical Procedures

Biocompatibles: The Perils of Re-Inventing a Public Company

The medical device industry is full of companies that started out focusing on one therapeutic area only to shift gears and apply their original or another technooloogy to a different clinical need. Indeed, Biocompatibles is now workiing on its third primary therapeutic areas--cancer--having previously sold off its first two businesses, in ophthalmology and then, convinced it was too far behind in drug-eluting stents, cardiovascular. This new growth area is being driven by the company's general expertise in polymer technology and drug delivery.
BioPharmaceutical Medical Device

Keys To Creating Value for Early-Stage Medical Device Companies

Small cap firms that reach a successful exit via M&A tend to share a set of chacteristics that enable significant value creation. Start-ups can use them as a template to gauge their own potential for success. Indeed, those characteristics, which include the development of a novel, best-in-breed technology with significant clinical impact, having a set of products that deliver a competitive edge, and careful execution of their respective business plans (including managing capital and timelines), can serve as a template for early-stage medical device companies, and help define the parameters necessary for them to engineer their way towards an outcome that maximizes value.
Business Strategies Business Strategies

Total Occlusions: Device Obstacle or Opportunity?

The market is promising for using catheters, instead of surgery, to open vascular blockages. But the right technology remains elusive.
Medical Device Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Hank Plain, Pres. & CEO
    Kenneth E Ludlum, CFO
    Ronald W Songer, VP, R&D
  • Contact Info
  • Perclose Inc.
    Phone: (650) 474-3000
    400 Saginaw Drive
    Redwood City, CA 94063
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register